Your browser doesn't support javascript.
loading
Blood transfusion safety in the country of Georgia: collateral benefit from a national hepatitis C elimination program.
Bloch, Evan M; Kipiani, Eteri; Shadaker, Shaun; Alkhazashvili, Maia; Gvinjilia, Lia; Kuchuloria, Tinatin; Chitadze, Nazibrola; Keating, Sheila M; Gamkrelidze, Amiran; Turdziladze, Alexander; Getia, Vladimer; Nasrullah, Muazzam; Averhoff, Francisco; Izoria, Mariam; Skaggs, Beth.
Afiliación
  • Bloch EM; Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
  • Kipiani E; National Center for Disease Control and Public Health, Tbilisi, Georgia.
  • Shadaker S; Division of Viral Hepatitis National Center for HIV, Hepatitis, STD&TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Alkhazashvili M; National Center for Disease Control and Public Health, Tbilisi, Georgia.
  • Gvinjilia L; South Caucasus Office of the U.S. Centers for Disease Control (CDC), Tbilisi, Georgia.
  • Kuchuloria T; South Caucasus Office of the U.S. Centers for Disease Control (CDC), Tbilisi, Georgia.
  • Chitadze N; National Center for Disease Control and Public Health, Tbilisi, Georgia.
  • Keating SM; Vitalant Research Institute (formerly Blood Systems Research Institute), San Francisco, California, USA.
  • Gamkrelidze A; University of California San Francisco, San Francisco, California, USA.
  • Turdziladze A; National Center for Disease Control and Public Health, Tbilisi, Georgia.
  • Getia V; National Center for Disease Control and Public Health, Tbilisi, Georgia.
  • Nasrullah M; National Center for Disease Control and Public Health, Tbilisi, Georgia.
  • Averhoff F; Division of Viral Hepatitis National Center for HIV, Hepatitis, STD&TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Izoria M; Division of Viral Hepatitis National Center for HIV, Hepatitis, STD&TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Skaggs B; National Center for Disease Control and Public Health, Tbilisi, Georgia.
Transfusion ; 60(6): 1243-1252, 2020 06.
Article en En | MEDLINE | ID: mdl-32542715
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Transfusión Sanguínea / Hepatitis C / Hepacivirus / Anticuerpos contra la Hepatitis C / Seguridad de la Sangre Tipo de estudio: Prognostic_studies Límite: Adolescent / Adult / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Transfusion Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Transfusión Sanguínea / Hepatitis C / Hepacivirus / Anticuerpos contra la Hepatitis C / Seguridad de la Sangre Tipo de estudio: Prognostic_studies Límite: Adolescent / Adult / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Transfusion Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos